ArticleBritish journal of clinical pharmacology2021

Economic evaluation of remdesivir for the treatment of severe COVID-19 patients in China under different scenarios.

Yawen Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.